Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 70.39% is 26% below its 5-year average of 95.33%, near the low end of its 5-year range (27.26%–202.28%).
As of the fiscal period ended Tuesday, June 30, 2026. 50.73% below its 12-month average of 142.86%.
Reported quarterly debt to assets ratio; no daily interpolation. Q3 FY2026 (2026-06-30): 70.39%.
DEBT TO ASSETS RATIO
70.39%
DEBT TO ASSETS RATIO AVG TTM
142.86%
DEBT TO ASSETS RATIO AVG 3Y
128.97%
DEBT TO ASSETS RATIO AVG 5Y
95.33%
DEBT TO ASSETS RATIO AVG 10Y
81.65%
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-50.73%
CURRENT VS 3Y AVG
-45.42%
CURRENT VS 5Y AVG
-26.17%
CURRENT VS 10Y AVG
-13.79%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+78109.53%
vs the sector median at left
Outlook Therapeutics, Inc.
Market Cap
$108.46M
Debt to Assets Ratio
70.39%
TTM Avg
142.86%
3Y Avg
128.97%
5Y Avg
95.33%
Market Cap
$108.33M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$108.66M
Debt to Assets Ratio
0.43%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$108.18M
Debt to Assets Ratio
0.07%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$109.91M
Debt to Assets Ratio
0.65%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$106.91M
Debt to Assets Ratio
0.03%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$105.19M
Debt to Assets Ratio
0.34%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$105.15M
Debt to Assets Ratio
0.14%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Outlook Therapeutics, Inc. (OTLK) | $108.46M | 70.39% | 142.86% | 128.97% | 95.33% |
| Aardvark Therapeutics, Inc. Common Stock (AARD)vs › | $108.33M | 0.01% | N/A | N/A | N/A |
| Vivani Medical, Inc. (VANI)vs › | $108.66M | 0.43% | N/A | N/A | N/A |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $108.18M | 0.07% | N/A | N/A | N/A |
| Immunic, Inc. (IMUX)vs › | $107.09M | 0.00% | N/A | N/A | N/A |
| Apyx Medical Corporation (APYX)vs › | $109.91M | 0.65% | N/A | N/A | N/A |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $106.91M | 0.03% | N/A | N/A | N/A |
| Definitive Healthcare Corp. (DH)vs › | $105.19M | 0.34% | N/A | N/A | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $105.15M | 0.14% | N/A | N/A | N/A |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $104.67M | 0.00% | N/A | N/A | N/A |
Debt/Assets
70.4%
Debt/Equity
N/A
Current Ratio
0.81
Interest Coverage
-236.9x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 70.39% |
| 2026-03-31 | 124.19% |
| 2025-12-31 | 202.28% |
| 2025-09-30 | 162.48% |
| 2025-06-30 | 154.96% |
| 2025-03-31 | 174.67% |
| 2024-12-31 | 182.46% |
| 2024-09-30 | 103.17% |
| 2024-06-30 | 69.49% |
| 2024-03-31 | 75.80% |
| 2023-12-31 | 168.53% |
| 2023-09-30 | 110.08% |
| 2023-06-30 | 78.16% |
| 2023-03-31 | 58.93% |
| 2022-12-31 | 50.81% |
| 2022-09-30 | 38.41% |
| 2022-06-30 | 27.26% |
| 2022-03-31 | 33.77% |
| 2021-12-31 | 28.49% |
| 2021-09-30 | 52.18% |
| 2021-06-30 | 35.52% |
| 2021-03-31 | 25.20% |
| 2020-12-31 | 90.17% |
| 2020-09-30 | 44.59% |
| 2020-06-30 | 29.28% |
| 2020-03-31 | 140.35% |
| 2019-12-31 | 140.02% |
| 2019-09-30 | 87.23% |
| 2019-06-30 | 45.09% |
| 2019-03-31 | 95.31% |
| 2018-12-31 | 95.84% |
| 2018-09-30 | 100.19% |
| 2018-06-30 | 64.11% |
| 2018-03-31 | 78.15% |
| 2017-12-31 | 53.34% |
| 2017-09-30 | 88.83% |
| 2017-06-30 | 99.17% |
| 2017-03-31 | 70.79% |
| 2016-12-31 | 53.68% |
| 2016-09-30 | 36.83% |
| 2016-06-30 | 28.00% |
| 2016-03-31 | 59.11% |
| 2015-12-31 | 45.83% |
| 2015-09-30 | 130.72% |
